FDA
Lopinavir and Ritonavir
The FDA lists this product in 12 strengths and forms.
Composition
- Active ingredients
- LOPINAVIR 40MG; RITONAVIR 10MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LOPINAVIR 100MG; RITONAVIR 25MG · TabletANDA079074-001 · Prescription
- LOPINAVIR 200MG; RITONAVIR 50MG · TabletANDA079074-002 · Prescription
- LOPINAVIR 100MG; RITONAVIR 25MG · TabletANDA091677-001 · Prescription
- LOPINAVIR 200MG; RITONAVIR 50MG · TabletANDA091677-002 · Prescription
- LOPINAVIR 200MG; RITONAVIR 50MG · TabletANDA204739-002 · Prescription
- LOPINAVIR 100MG; RITONAVIR 25MG · TabletANDA204739-001 · Prescription
- LOPINAVIR 80MG/ML; RITONAVIR 20MG/ML · SolutionANDA207407-001 · Discontinued
- LOPINAVIR 100MG; RITONAVIR 25MG · TabletANDA214696-001 · Prescription
- LOPINAVIR 200MG; RITONAVIR 50MG · TabletANDA214696-002 · Prescription
- LOPINAVIR 40MG; RITONAVIR 10MG · PelletsThis page
- LOPINAVIR 100MG; RITONAVIR 25MG · TabletANDA213857-001 · Prescription
At a glance
- Brand name
- Lopinavir and Ritonavir
- Active substance
- lopinavir
- Route
- Oral
- Dosage form
- Pellets
- Applicant
- Cipla LTD
- Status
- Tentative approval
- FDA approval
- 21 May 2015
- Application
- NDA205425-001